The conversation about cannabis and mental health is politically charged. Cannabis advocates often dismiss the link with psychosis as moral panic. Cannabis critics often overstate it as direct causation. The truth is in between, and it's well documented enough that people with risk factors should know.
Cannabis use, especially heavy use of high-THC products during adolescence, increases the risk of developing psychosis and schizophrenia. The risk is concentrated in people who already have a vulnerability. Most cannabis users do not develop psychosis.
What the studies show
The link between cannabis and psychosis is one of the most replicated findings in psychiatric epidemiology over the past three decades. Key findings:
- Heavy cannabis use roughly doubles the lifetime risk of psychotic disorder (Moore et al., Lancet 2007 meta-analysis)
- Daily use of high-potency cannabis (THC content >10%) increases risk roughly 5-fold (Di Forti et al., Lancet Psychiatry 2019)
- Earlier age of first use increases risk substantially — adolescent use carries more risk than adult use
- Family history of psychosis further multiplies risk in cannabis users
- Population-level effects — studies estimate that 8–24% of first-episode psychosis cases in major European cities would not have occurred without high-potency cannabis use
What this doesn't mean
- It doesn't mean cannabis directly causes schizophrenia in everyone who uses it. Most cannabis users never develop psychosis.
- It doesn't mean cannabis is the only or main cause of schizophrenia. Genetics, brain development, and other factors are larger contributors.
- It doesn't mean low-THC, infrequent adult use carries the same risk as daily teenage use of high-THC concentrates.
What this does mean
- If you have a family history of psychosis or schizophrenia, your personal risk from cannabis use is meaningfully higher than the general population
- If you have already had a psychotic episode, ongoing cannabis use significantly increases the risk of relapse
- If you are an adolescent, your developing brain is particularly vulnerable
- High-THC concentrates (>15% THC, including most modern flower and concentrates) carry meaningfully more risk than older, lower-potency cannabis
Cannabis-induced psychosis
This is a distinct diagnosis — psychotic symptoms that begin during or shortly after cannabis use and last beyond the period of intoxication. About a quarter of people who experience cannabis-induced psychosis go on to develop a primary psychotic disorder (schizophrenia, bipolar with psychosis) within several years. For some, the cannabis episode is the first manifestation of a vulnerability that would have shown itself eventually. For others, it appears to be the trigger.
Mechanisms (briefly)
The dominant theory: THC acts on the brain's CB1 receptor, which is involved in dopamine regulation. In vulnerable brains, repeated THC exposure may sensitise dopamine systems involved in psychosis. CBD (the non-psychoactive cannabinoid) may have opposing effects — which is partly why high-THC, low-CBD strains are higher-risk than balanced strains.
If you already have schizophrenia
Continuing cannabis use after a diagnosis of schizophrenia substantially increases the risk of:
- Relapse
- More frequent hospitalisations
- Poorer response to antipsychotic medication
- Worse cognitive function
- Reduced engagement with treatment
This is not a moral judgment — it's epidemiology. Cessation of cannabis use is one of the strongest predictors of long-term recovery in schizophrenia.
What about medical cannabis or CBD?
CBD (without THC) does not appear to carry the same psychosis risk and has actually been studied as a potential adjunctive treatment for schizophrenia. THC-containing medical cannabis carries the same risks as recreational cannabis.
What helps if you want to stop
- Acknowledge that withdrawal is real (sleep disturbance, irritability, appetite changes for 1–2 weeks)
- Work with a clinician — for people with schizophrenia, dual-diagnosis support is often most effective
- Address the underlying reasons for use (sleep, anxiety, social) with non-cannabis strategies
- Build structure during the first weeks (most relapses happen in unstructured time)
- Track substance use alongside mood — apps like Frida can help
This article is for educational purposes only and is not medical advice.